col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


114 Results       Page 1

 [1] 
Bentham Science: Current Pharmaceutical Design
  original article Date Title Authors   All Authors
1 [GO] 2023―Sep―06 Salivary antiviral and antibacterial properties in the encounter of SARS-CoV-2 Nooshin Mohtasham, Rahimeh Bargi, Alieh Farshbaf, Maryam Vahabzadeh Shahri, Kiana Kamyab Hesari, Farnaz Mohajertehran
2 [GO] 2023―Aug―16 Acute Kidney Injury (AKI) in COVID-19: In silico Identification of LncRNA-MiRNA-Gene Networks and Key Transcription Factors Somayeh Hashemi Sheikhshabani, Zeinab Amini-Farsani, Nesa Kazemifard, Parastoo Modarres, Sharareh Khazaei Feyzabad, Zahra Amini-Farsani, et al. (+3)
3 [GO] 2023―Jul―30 Nanotechnology-based Approaches and Investigational Therapeutics against COVID-19
4 [GO] 2023―Jul―30 Repositioning Therapeutics for SARS-CoV-2: Virtual Screening of Plant-based Anti-HIV Compounds as Possible Inhibitors against COVID-19 Viral RdRp
5 [GO] 2023―May―17 Electroacupuncture in Regulating Gastrointestinal Symptoms of COVID-19: A Mini-review Xianqiang Yu, Yingjie Wang
6 [GO] 2023―May―11 Exploring the potential mechanism of action of ursolic acid against gastric cancer and COVID-19 using network pharmacology and bioinformatics analysis Hailiang Huang, Zhiyao Liu, Ying Yu, Yuqi Jia, Lingling Li, Xin Shi, Fangqi Wang
7 [GO] 2023―Jan―03 Experimental and Computational Approaches for SARS-CoV-2 Theranostics Ijaz Gul, Mohammad Amjad Kamal
8 [GO] 2022―Dec―21 In-Silico Study of Resveratrol as Multi-Edged Potent Inhibitor against SARS-Cov-2 and Variants of Concern Using Molecular Dynamic Simulation and PCA Analysis Amaresh Kumar Sahoo, Vishal Singh, Vidhu Agarwal, Pritish Kumar Varadwaj
9 [GO] 2022―Dec―07 Therapeutic Applications of Fucoidans and their Potential to Act against COVID-19 Dhananjay Yadav, Minseok Song
10 [GO] 2022―Dec―06 In Silico Studies Reveal Antiviral Effects of Traditional Indian Spices on COVID-19 Brijesh Kumar
11 [GO] 2022―Dec―06 Repurposing Drugs for the Management of Patients with Confirmed Coronavirus Disease 2019 (COVID-19) Evellyn Claudia Wietzikoski Lovato
12 [GO] 2022―Dec―06 Use of Natural Compounds as a Potential Therapeutic Agent Against COVID-19 Shadma Wahab
13 [GO] 2022―Dec―06 Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19 Yasanandana S. Wijayasinghe
14 [GO] 2022―Dec―06 Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19 Md. Tabish Rehman
15 [GO] 2022―Dec―06 Prevention Knowledge and Its Practice Towards COVID-19 Among General Population of Saudi Arabia: A Gender-based Perspective Freah Alshammary
16 [GO] 2022―Dec―06 COVID-19 and Domestic Animals: Exploring the Species Barrier Crossing, Zoonotic and Reverse Zoonotic Transmission of SARS-CoV-2 Rajesh Kumar
17 [GO] 2022―Dec―06 Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments Clodoveo Ferri
18 [GO] 2022―Dec―06 The Association of Respiratory Viruses with Oxidative Stress and Antioxidants. Implications for the COVID-19 Pandemic Marina Darenskaya
19 [GO] 2022―Dec―06 Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients Kholoud F. Aliter
20 [GO] 2022―Dec―06 Therapeutic Management of COVID-19 Patients: Clinical Manifestation and Limitations Urooj Fatima
21 [GO] 2022―Dec―06 COVID-19 Vaccines in Clinical Trials and their Mode of Action for Immunity against the Virus Shima Tavakol
22 [GO] 2022―Dec―06 Clinical Review of COVID-19; Pathogenesis, Diagnosis, and Management Hussien Ahmed H. Abdelgawad
23 [GO] 2022―Dec―06 Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Khojasteh Malekmohammad
24 [GO] 2022―Dec―06 miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis Rohit Satyam
25 [GO] 2022―Dec―06 Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm Monireh Torabi-Rahvar
26 [GO] 2022―Dec―06 Natural Agents Modulating ACE-2: A Review of Compounds with Potential against SARS-CoV-2 Infections Arquimedes Gasparotto Junior
27 [GO] 2022―Nov―24 Host-Cell Surface Binding Targets in SARS-COV-2 for Drug Design Sayyed Abbas Tabatabai, Hanieh Maleksabet, Elham Rezaee
28 [GO] 2022―Nov―08 Current insights and molecular docking studies of the drugs under clinical trial as rdrp inhibitors in COVID-19 treatment Amita Verma, Pradeep Kumar, Irine Pauly, Ankit Kumar Singh, Adarsh Kumar, Yogesh Singh, et al. (+2)
29 [GO] 2022―Oct―28 Mast Cell's Role in Cytokine Release Syndrome and Related Manifestations of COVID-19 Disease Öner Özdemir, Azize Yasemin Göksu Erol, Ümmügülsüm Dikici
30 [GO] 2022―Oct―26 Nitric oxide and its derivatives containing nasal spray and inhalation therapy for the treatment of COVID-19 Vivek P Chavda, Lalitkumar K Vora, Rajeev K. Singla, Aayushi B. Patel, Priyal Shah, Vladimir N. Uversky, Vasso Apostolopoulos
31 [GO] 2022―Oct―21 Vaccination against SARS-CoV-2 protects from COVID-19-induced endothelial dysfunction Evangelos Oikonomou, Stamatios Lampsas, Nektarios Souvaliotis, Savvas Sarantos, Gerasimos Siasos, Garyphallia Poulakou, et al. (+10)
32 [GO] 2022―Oct―20 State-of-the-art tools to elucidate the therapeutic potential of TAT-peptide (TP) conjugated repurposing drug against SARS-CoV-2 spike glycoproteins Mohammad Azam Ansari, Mohammad N. Alomary, Qazi Mohammad Sajid Jamal, Yosif Almoshari, Ahmed Salawi, Suliman A. Alhmahmoud, Johra Khan
33 [GO] 2022―Oct―18 Use of Natural Compounds as a Potential Therapeutic Agent Against COVID-19 Shadma Wahab
34 [GO] 2022―Oct―18 COVID-19 Outbreak and Emerging Management through Pharmaceutical Therapeutic Strategy Md. Rahman
35 [GO] 2022―Oct―18 COVID-19 Vaccines in Clinical Trials and their Mode of Action for Immunity against the Virus Shima Tavakol
36 [GO] 2022―Sep―27 Clinical Consideration for Mesenchymal Stem Cells in Treatment of COVID-19 Kang-Hsi Wu, Yu-Hua Chao, Te-Fu Weng, Ju-Pi Li
37 [GO] 2022―Sep―09 Tetraspanin-enriched Microdomain Containing CD151, CD9, and TSPAN 8 - Potential Mediators of Entry and Exit Mechanisms in Respiratory Viruses Including SARS-CoV-2 RamaRao Malla, Mohammad Amjad Kamal
38 [GO] 2022―Aug―02 Herbal medicines as potential inhibitors of SARS-CoV-2 infection Soodabeh Rostami, Shima Gharibi, Hajar Yaghoobi, Zary Nokhodian, Parisa Shoaei, Armina Alaghband Bahrami, et al. (+2)
39 [GO] 2022―Aug―01 COVID-19: Pathophysiology, transmission, and drug development for therapeutic treatment and vaccination strategies Vishal Kumar Singh, Himani Chaurasia, Richa Mishra, Ritika Srivastava, Aditya K. Yadav, Jayati Dwivedi, et al. (+2)
40 [GO] 2022―Jul―22 Cytokine Release Syndrome in Pathogenesis and Treatment of COVID-19 Tao Hu, Chi Hin Cho
41 [GO] 2022―Jul―22 An Update on Promising Agents against COVID-19: Secondary Metabolites and Mechanistic Aspects Maryam Jamshidnia, Robert D. E. Sewell, Mahmoud Rafieian-Kopaei
42 [GO] 2022―Jul―17 Natural Agents Modulating ACE-2: A Review of Compounds with Potential against SARS-CoV-2 Infections Gasparotto A.
43 [GO] 2022―Jul―14 A review of current evidence from cardiovascular manifestations and outcomes in patients with COVID-19 Shirin Saberianpour, Elahe Aleebrahim-Dehkordi, Elaheh Mazaheri, Ali Hasanpour-Dehkordi
44 [GO] 2022―Jul―14 Prolonged NHE Activation may be Both Cause and Outcome of Cytokine Release Syndrome in COVID-19 Medine Cumhur Cure, Erkan Cure
45 [GO] 2022―Jul―14 Therapeutic potential of P2X7 purinergic receptor modulation in the main organs affected by the COVID-19 cytokine storm Júlia Leão Batista Simões, Leilane Dayane Sobierai, Stefany Maciel Pereira, Miriam Vitória Rodrigues dos Santos, Margarete Dulce Bagatini
46 [GO] 2022―Jul―04 COVID-19 Challenge: A Quest for Effective Vaccine Strategies Against Circulating and Emerging SARS-CoV-2 Variants Ruchika Yogesh, Noopur Srivastava, Syed Nasir Abbas Bukhari
47 [GO] 2022―Jun―21 Prevalence and death rate of COVID-19 in systemic autoimmune diseases in the first three pandemic waves. Relationship to disease subgroups and ongoing therapies Clodoveo Ferri, Vincenzo Raimondo, Laura Gragnani, Dilia Giuggioli, Lorenzo Dagna, Antonio Tavoni, et al. (+78)
48 [GO] 2022―Jun―07 Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part V) Mohammad Amjad Kamal, Md Asaduzzaman Khan
49 [GO] 2022―May―27 Main Diagnostic Methods for Covid-19: Integrative Review Ana Sara Martins de Campos, Giandra Azolini Fernandes de Souza, Renan Almeida de Jesus, Giuliana Zardeto, Guilherme Donadel, Mariana Dalmagro, et al. (+7)
50 [GO] 2022―May―22 Immunopathogenesis and immunogenetic variants in COVID-19 Pakorn Sagulkoo, Kitiporn Plaimas, Apichat Suratanee, Andrea Name Colado Simão, Edna Maria Vissoci Reiche, Michael Maes
51 [GO] 2022―May―07 Can we s쳮d in the fight against SARS-CoV-2 with its emerging new variants? Shima Tavakol, Hani Tavakol, Mo S. Alavijeh, Alexander Seifalian
52 [GO] 2022―Apr―30 Repositioning therapeutics for SARS-CoV-2: Virtual screening of plant-based Anti-HIV compounds as possible inhibitors against COVID-19 viral RdRp Mahadevamurthy Murali, Hittanahallikoppal Gajendramurthy Gowtham, Mohammad Azam Ansari, Mohammad N. Alomary, Saad Alghamdi, Mazen Almehmadi, et al. (+6)
53 [GO] 2022―Apr―20 Interaction of Vitamin D and Corticosteroid Use in Hospitalized COVID-19 Patients: A Potential Explanation for Inconsistent Findings in the Literature Jimmy T. Efird, Ethan Anderson, Charulata Jindal, Ayako Suzuki
54 [GO] 2022―Mar―29 Ivabradine in the management of COVID-19-related cardiovascular complications: A perspective Tomas Baka, Kristina Repova, Ivan Luptak, Fedor Simko
55 [GO] 2022―Mar―23 Alterations in clinical characteristics of blood donors post COVID-19 recovery Fahad Al Ghamdi, Salma Naqvi, Fahad A. Alabassi, Sultan Alhayyani, Mirza Rafi Baig, Vikas Kumar, Firoz Anwar
56 [GO] 2021―Dec―13 A review of the rational and current evidence on colchicine for COVID-19 Hazem S. Ghaith, Mohamed Diaa Gabra, Mohamed H. Nafady, Hamza Emad Elshawah, Ahmed Negida, Mohammad Amjad Kamal
57 [GO] 2021―Oct―22 Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part IV) Md Asaduzzaman Khan, Mohammad Amjad Kamal
58 [GO] 2021―Oct―21 Covid-19 Epidemiology, Pathogenesis and Therapy Alessandro Antonelli, Clodoveo Ferri
59 [GO] 2021―Oct―14 Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part III) Md Asaduzzaman Khan, Mohammad Amjad Kamal
60 [GO] 2021―Sep―03 Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments Clodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, Massimo L’Andolina, Lorenzo Dagna, Antonio Tavoni, et al. (+79)
61 [GO] 2021―Sep―01 Nanotechnology-Based Strategies for the Management of COVID-19: Recent Development and Challenges Ritu Singh, Monalisha Behera, Nisha Kumari, Sanjeev Kumar, Vishnu D. Rajput, Tatiana M Minkina, et al. (+3)
62 [GO] 2021―Sep―01 The Use of Lectins as Tools to Combat SARS-CoV-2 Daniela Martinez, Diego Amaral, David Markovitz, Luciano Pinto
63 [GO] 2021―Jul―16 Synopsis on Pharmotechnological Approaches in Diagnostic to Management Strategies in Fighting Against COVID-19 Asim Azhar, Nazia Hassan, Manvi Singh, Khaled Al-hosaini, Mohammad Amjad Kamal
64 [GO] 2021―Jul―06 Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Khojasteh Malekmohammad, Mahmoud Rafieian-Kopaei
65 [GO] 2021―Jul―05 Nanotechnology-Based Approaches and Investigational Therapeutics against COVID-19 Md. Mominur Rahman, Muniruddin Ahmed, Mohammad Touhidul Islam, Md. Robin Khan, Sharifa Sultana, Saila Kabir Maeesa, et al. (+6)
66 [GO] 2021―Jun―10 Different Methods for Molecular and Rapid Detection of Human Novel Coronavirus Mohamad Hesam Shahrajabian, Wenli Sun, Qi Cheng
67 [GO] 2021―Jun―09 The roles of vitamin D in increasing the body's immunity and reducing injuries due to viral infections: With an emphasis on its possible role in SARS-CoV-2 (COVID-19) Elahe Aleebrahim-Dehkordi, Niloofar Deravi, Shirin Yaghoobpoor, Dariush Hooshyar, Mahmoud Rafieian-Kopaei
68 [GO] 2021―May―22 Preventive and Therapeutic Strategies to Fight COVID-19 Alexander Marcus Seifalian, Shima Tavakol
69 [GO] 2021―Mar―24 Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part II) Md Asaduzzaman Khan, Mohammad Amjad Kamal
70 [GO] 2021―Mar―16 Tocilizumab: From Rheumatic Diseases to Covid-19 Alberto Raiteri, Fabio Piscaglia, Alessandro Granito, Francesco Tovoli
71 [GO] 2021―Mar―03 Identification of the interaction between Angiotensin-converting Enzyme Residues and Severe Acute Respiratory Syndrome Coronavirus 2. Youness Kadil, Mohammed Mouhcine, Imane Rahmoune, Houda Filali
72 [GO] 2021―Mar―03 Diabetes and COVID-19; a review of possible mechanisms Reyhaneh Moradi-Marjaneh, Fereshteh Asgharzadeh, Elnaz Khordad, Mahdi Moradi Marjaneh
73 [GO] 2021―Feb―25 COVID-19: Epidemiology, Pathology, Diagnosis, Treatment, and Impact Saimon Shahriar, Md. Sohel Rana, Md. Sabbir Hossain, Ariful Karim, Tasneem Nayla Mredula, Nadia Nourin, et al. (+2)
74 [GO] 2021―Feb―23 The association of respiratory viruses with oxidative stress and antioxidants. Implications for the COVID-19 pandemic Marina Darenskaya, Liubov Kolesnikova, Sergei Kolesnikov
75 [GO] 2021―Feb―04 Nano-Biomaterials as Sensing and Therapeutic Tool to Mitigate Viral Pathogenesis with Special Reference to COVID-19 Pallavi Singh Chauhan, Dhananjay Yadav, Anuj Dubey, Jun-O Jin
76 [GO] 2021―Jan―26 The computational intervention of macrolide antibiotics in the treatment of COVID-19 Firoz Anwar, Hisham N. Altayb, Fahad A. Al-Abbasi, Vikas Kumar, Mohammad Amjad Kamal
77 [GO] 2021―Jan―26 Emerging therapeutic approaches to COVID-19 Indrakant Kumar Singh, Pratibha Kumari, Pooja Mittal, Amit Kumar, Bharti Singal, Gulam Mustafa Hasan, et al. (+4)
78 [GO] 2021―Jan―18 Therapeutic agents against COVID-19 with clinical evidence Cheng Tian, Ming Xiang
79 [GO] 2021―Jan―18 Natural agents modulating ACE-2: A review of compounds with potential against SARS-CoV-2 infections Arquimedes Gasparotto Junior, Sara Emília Lima Tolouei, Francislaine Aparecida dos Reis Lívero, Francielli Gasparotto, Thaise Boeing, Priscila de Souza
80 [GO] 2021―Jan―12 In silico Prediction and Designing of Potential siRNAs to be Used as Antivirals Against SARS-CoV-2 Sayed Sartaj Sohrab, Sherif Aly El-Kafrawy, Aymn T. Abbas, Leena H. Bajrai, Esam Ibraheem Azhar
81 [GO] 2021―Jan―12 Natural Products, a Potential Therapeutic Modality in Management and Treatment of nCoV-19 Infection: Preclinical and Clinical based Evidence Ashif Iqubal, Mohammad Kashif Iqubal, Musheer Ahmed, Syed Ehtaishamul Haque
82 [GO] 2021―Jan―04 COVID-19: An Update on Pathogenesis and Treatment Marwa Abduallah AL Dhamen, Abrar Fouad Alhashim, Hawra Hussain Alqattan, Faheem Hyder Pottoo
83 [GO] 2021―Jan―04 Emergence and Reemergence of Human Coronaviruses: Spike Protein as the Potential Molecular Switch and Pharmaceutical Target Fahim Ahmad, Mohammad A. Kamal, Babu L. Tekwani
84 [GO] 2021―Jan―03 Use of Natural Compounds as a potential therapeutic agent against COVID-19 Shadma Wahab, Irfan Ahmad, Safia Irfan, Mohammad Hassan Baig, Abd-ElAziem Farouk, Jae-Jun Dong
85 [GO] 2020―Dec―24 In silico studies reveal antiviral effects of traditional Indian spices on COVID-19 Brijesh Kumar, Sama Zaidi, Shafiul Haque, Nandita Dasgupta, Arif Hussain, Sreepoorna Unni, et al. (+2)
86 [GO] 2020―Dec―23 A Clinical Review of COVID-19; Pathogenesis, Diagnosis, and Management Hussien Ahmed, Ahmed Sayed, Malak Munir, Mostafa H. Elberry, Ibrahim M Sayed, Mohammed Amjad Kamal, et al. (+3)
87 [GO] 2020―Dec―14 An Overview of Natural and Synthetic Analogs of Quinoline for the Prophylaxis of COVID-19. Chloroquine Analogs: An Overview of Natural and Synthetic Quinolines as Broad Spectrum Antiviral Agents Veera Bramhachari Pallaval, Manasa Kanithi, Sangeetha Meenakshisundaram, Achanta Jagadeesh, Mattareddy Alavala, Thanigaimalai Pillaiyar, et al. (+2)
88 [GO] 2020―Dec―11 Anti-malarial Drugs are Not Created Equal for SARS-CoV-2 Treatment: A Computational Analysis Evidence Simone Ronsisvalle, Federica Panarello, Rosaria Di Mauro, Renato Bernardini, Giovanni Li Volti, Giuseppina Cantarella
89 [GO] 2020―Dec―11 Silybin B and Cianidanol Inhibit M pro and Spike Protein of SARS-CoV-2: Evidence from in Silico Molecular Docking Studies Rashi Srivastava, Shubham Tripathi, Sreepoorna Unni, Arif Hussain, Shafiul Haque, Nandita Dasgupta, et al. (+2)
90 [GO] 2020―Dec―05 COVID-19 Impacts, Diagnosis and Possible Therapeutic Techniques: A Comprehensive Review Ayesha Aziz, Muhammad Asif, Ghazala Ashraf, Qiaoli Yang, Shenqi Wang
91 [GO] 2020―Dec―03 Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A new Route to Fight against COVID-19? Shah Khalid, Faisal A. Almalki, Taibi Ben Hadda, Ammar Bader, Tareq Abu-Izneid, Malika Berredjem, et al. (+2)
92 [GO] 2020―Nov―30 Viral Diseases and Natural Products: Prospects in COVID-19 Treatment Mohammad Amjad Kamal, Md Asaduzzaman Khan
93 [GO] 2020―Nov―26 Therapeutic management of COVID-19 patients: Clinical manifestation and limitations Urooj Fatima, Syed Saif Abbas Rizvi, Neha Raina, Saher Fatima, Safikur Rahman, Mohammad Amjad Kamal, Md. Imtaiyaz Hassan
94 [GO] 2020―Nov―26 Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm Monireh Torabi-Rahvar, Nima Rezaei
95 [GO] 2020―Nov―20 Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19 Yasanandana Supunsiri Wijayasinghe, Pravin Bhansali, Ronald E. Viola, Mohammad A. Kamal, Nitesh Kumar Poddar
96 [GO] 2020―Nov―20 Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19 Md Tabish Rehman, Mohamed F. AlAjmi, Afzal Hussain
97 [GO] 2020―Nov―20 COVID-19 and domestic animals: Exploring the species barrier crossing, zoonotic and reverse zoonotic transmission of SARS-CoV-2 Rajesh Kumar, Seetha Harilal, Abdullah G. Al-Sehemi, Mehboobali Paninipara, Tapan Behl, Githa Elizabeth Mathew, Bijo Mathew
98 [GO] 2020―Nov―20 Coronavirus Disease -2019 (COVID-19) in 2020: A Perspective Study of a Global Pandemic Mujtaba Aamir Bhat, Safikur Rahman, Irfan Ahmad Rather, Iqbal Banday, Shafiya Syed, Hamira Koser, et al. (+3)
99 [GO] 2020―Nov―20 The impact of traditional plants and their secondary metabolites in the discovery of COVID-19 treatment Shabana Bibi, Ayesha Sarfraz, Ghazala Mustafa, Zeeshan Ahmed, Muhammad Aurang Zeb, Yuan-Bing Wang, et al. (+4)
100 [GO] 2020―Nov―06 Current landscape of natural products against coronaviruses: perspectives in COVID-19 treatment and antiviral mechanism Jakaria Shawon, Zakia Akter, Md. Munnaf Hossen, Yeasmin Akter, Abu Sayeed, Md Junaid, et al. (+2)
101 [GO] 2020―Nov―06 Properties of Ethno-Medicinal Plants and Their Bioactives-Possible Use for Prevention and Treatment of COVID-19: A Review Ambreen Shoaib, Lubna Azmi, Ila Shukla, Saad S. Alqahtani, Ibrahim A. Alsarra, Faiyaz Shakeel
102 [GO] 2020―Oct―26 COVID-19 Vaccines on Clinical Trials and their Mode of Action for Immunity against the Virus Shima Tavakol, Mo S. Alavijeh, Alexander M. Seifalian
103 [GO] 2020―Oct―16 The undiscovered potential of essential oils for treating SARS-CoV-2 (COVID- 19) Peter J. Wilkin, Minnatallah Al-Yozbaki, Alex George, Girish Kumar Gupta, Cornelia M. Wilson
104 [GO] 2020―Oct―02 miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis Rohit Satyam, Tulika Bhardwaj, Sachin Goel, Niraj Kumar Jha, Saurabh Kumar Jha, Parma Nand, et al. (+3)
105 [GO] 2020―Oct―01 Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients Kholoud F. Aliter, Rami A. Al-Horani
106 [GO] 2020―Sep―11 Emerging Novel Coronavirus is a Global Threat: Insight in the Biology of COVID-19 and its Hijacking Process of Hosts’ Cell Debmalya Roy, Ipshita Khanra, Zeling Wang, Siva Bharath Merugu, Fakhar-un-Nisa Yunus, Dhahiri Saidi Mashausi, Dawei Li
107 [GO] 2020―Sep―03 Targeting Natural Products for the Treatment of COVID-19 - An Updated Review Ramachandra Reddy Pamuru, Naveen Ponneri, Amooru G Damu, Ramakrishna Vadde
108 [GO] 2020―Aug―26 Emergence of human pathogenic Coronaviruses: Lectins as antivirals for SARS-CoV-2 Sayed Sartaj Sohrab, Mohd Suhail, Mohammad Amjad Kamal, Fahim Ahmad, Esam Ibraheem Azhar
109 [GO] 2020―Aug―26 Neutralization of SARS-CoV-2 Spike Protein via Natural Compounds: A Multi Layered High Throughput Virtual Screening Approach Anupam Dhasmana, Vivek Kumar Kashyap, Swati Dhasmana, Sudhir Kotnala, Shafiul Haque, Ghulam Md Ashraf, et al. (+3)
110 [GO] 2020―Aug―19 Prevention Knowledge and Its Practice Towards COVID-19 Among General Population of Saudi Arabia: A Gender-based Perspective Freah Alshammary, Ammar Ahmed Siddiqui, Junaid Amin, Muhammad Ilyas, Hassaan Anwer Rathore, Ibne Hassan, et al. (+2)
111 [GO] 2020―Aug―13 Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the “Cytokine Release (Storm) Syndrome” Caused by SARS-CoV-2? Francisco José López-Iranzo, Ana María López-Rodas, Luis Franco, Gerardo López-Rodas
112 [GO] 2020―Jul―22 A Case Study: Analysis of Patents of Coronaviruses and Covid-19 for Technology Assesment and Future Research Pankaj Musyuni, Geeta Aggarwal, Manju Nagpal, Ramesh K. Goyal
113 [GO] 2020―Jul―14 Current Status of the COVID-19 Outbreak and Emerging Management through Pharmaceutical Therapeutic Strategy Tapan Behl, Md. Habibur Rahman, Rokeya Akter, Md. Arifur Rahman Chowdhury, Manirujjaman Mohammed, Israt Jahan Bulbul, et al. (+2)
114 [GO] 2020―Jul―07 Repurposing Drugs for the Management of Patients with Confirmed Coronavirus Disease 2019 (COVID-19) Evellyn Claudia Wietzikoski Lovato, Lorena Neris Barboza, Samantha Wietzikoski, Amanda Nascimento Vasques de Souza, Pablo Alvarez Auth, Arquimedes Gasparotto Junior, Francislaine Aparecida dos Reis Lívero
 [1] 

114 Results       Page 1


[de][en]

Last change 2023―Apr―13 19:50:14 UTC

© Daten-Quadrat 2022       Done in 0.005 sec